uniQure (QURE) Financials

$14.77 -0.23 (-1.53%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$15.04 +0.27 (+1.83%)

As of 04:44 AM Eastern

Annual Income Statements for uniQure

This table shows uniQure's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-127	-308	-240
Consolidated Net Income / (Loss)	-127	-308	-240
Net Income / (Loss) Continuing Operations	-127	-308	-240
Total Pre-Tax Income	-128	-307	-237
Total Operating Income	-143	-283	-184
Total Gross Profit	105	16	26
Total Revenue	106	16	27
Operating Revenue	106	16	27
Total Cost of Revenue	1.25	0.07	1.27
Operating Cost of Revenue	1.25	0.07	1.27
Total Operating Expenses	248	299	210
Selling, General & Admin Expense	56	76	57
Research & Development Expense	198	215	144
Other Operating Expenses / (Income)	-5.08	7.50	9.13
Total Other Income / (Expense), net	15	-24	-53
Interest Expense	12	42	64
Interest & Investment Income	0.61	20	21
Other Income / (Expense), net	26	-1.69	-11
Income Tax Expense	-1.47	1.92	2.43
Basic Earnings per Share	($2.71)	($6.47)	($4.92)
Weighted Average Basic Shares Outstanding	46.74M	47.67M	48.65M
Diluted Earnings per Share	($2.71)	($6.47)	($4.92)
Weighted Average Diluted Shares Outstanding	46.74M	47.67M	48.65M
Weighted Average Basic & Diluted Shares Outstanding	46.98M	47.84M	54.08M

This table shows uniQure's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-48	6.81	-77	-68	-90	-73	-66	-56	-44	-73
Consolidated Net Income / (Loss)	-48	6.81	-77	-68	-90	-73	-66	-56	-44	-73
Net Income / (Loss) Continuing Operations	-48	6.81	-77	-68	-90	-73	-66	-56	-44	-73
Total Pre-Tax Income	-48	6.60	-78	-68	-90	-70	-65	-55	-44	-72
Total Operating Income	-60	27	-74	-65	-82	-62	-54	-44	-40	-46
Total Gross Profit	1.45	101	5.33	2.42	1.41	6.62	8.34	11	2.02	4.60
Total Revenue	1.45	103	5.33	2.42	1.41	6.69	8.49	11	2.29	5.22
Operating Revenue	1.45	103	5.33	2.42	1.41	6.69	8.49	11	2.29	5.22
Total Cost of Revenue	0.00	1.25	0.00	0.00	0.00	0.07	0.15	0.23	0.26	0.62
Operating Cost of Revenue	-	-	0.00	0.00	0.00	0.07	0.15	0.23	0.26	0.62
Total Operating Expenses	61	75	79	67	83	68	63	55	42	50
Selling, General & Admin Expense	14	18	18	21	18	19	14	16	13	14
Research & Development Expense	48	58	61	46	65	43	41	34	31	39
Other Operating Expenses / (Income)	-0.62	-1.79	0.62	0.05	-0.42	7.25	7.70	5.24	-1.83	-1.98
Total Other Income / (Expense), net	11	-20	-4.26	-3.24	-7.76	-8.42	-11	-11	-4.18	-27
Interest Expense	3.07	3.43	3.56	6.84	15	16	16	16	17	15
Interest & Investment Income	0.04	0.49	1.67	3.23	7.50	7.17	6.51	5.81	4.87	4.24
Other Income / (Expense), net	14	-17	-2.37	0.37	0.19	0.12	-1.15	-0.99	7.56	-16
Income Tax Expense	-0.33	-0.21	-1.21	0.16	-0.07	3.03	0.66	0.95	-0.03	0.86
Basic Earnings per Share	($1.02)	$0.15	($1.63)	($1.44)	($1.88)	($1.52)	($1.36)	($1.16)	($0.91)	($1.49)
Weighted Average Basic Shares Outstanding	46.77M	46.74M	47.44M	47.65M	47.77M	47.67M	48.38M	48.62M	48.72M	48.65M
Diluted Earnings per Share	($1.02)	$0.15	($1.63)	($1.44)	($1.88)	($1.52)	($1.36)	($1.16)	($0.91)	($1.49)
Weighted Average Diluted Shares Outstanding	46.77M	46.74M	47.44M	47.65M	47.77M	47.67M	48.38M	48.62M	48.72M	48.65M
Weighted Average Basic & Diluted Shares Outstanding	46.82M	46.98M	47.58M	47.70M	47.81M	47.84M	48.55M	48.70M	48.74M	54.08M

This table details how cash moves in and out of uniQure's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-328	13	-84
Net Cash From Operating Activities	-145	-146	-183
Net Cash From Continuing Operating Activities	-145	-145	-183
Net Income / (Loss) Continuing Operations	-127	-308	-240
Consolidated Net Income / (Loss)	-127	-308	-240
Depreciation Expense	8.54	12	13
Amortization Expense	0.00	-11	-11
Non-Cash Adjustments To Reconcile Net Income	-27	179	76
Changes in Operating Assets and Liabilities, net	0.15	-16	-21
Net Cash From Investing Activities	-183	-206	163
Net Cash From Continuing Investing Activities	-183	-206	163
Purchase of Property, Plant & Equipment	-18	-7.15	-3.37
Acquisitions	-1.90	0.00	0.00
Purchase of Investments	-163	-366	-360
Sale and/or Maturity of Investments	0.00	168	534
Other Investing Activities, net	0.00	0.00	-8.32
Net Cash From Financing Activities	1.45	363	-59
Net Cash From Continuing Financing Activities	1.45	363	-59
Repayment of Debt	0.00	-4.29	-53
Issuance of Common Equity	1.45	0.31	2.12
Other Financing Activities, net	0.00	367	-8.56
Effect of Exchange Rate Changes	-1.83	2.27	-4.97
Cash Interest Paid	9.25	17	21

This table details how cash moves in and out of uniQure's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-60	-212	-74	360	-284	12	1.69	45	-38	-93
Net Cash From Operating Activities	-49	-55	-78	-57	39	-50	-61	-33	-37	-53
Net Cash From Continuing Operating Activities	-49	-55	-78	-57	39	-48	-61	-33	-37	-53
Net Income / (Loss) Continuing Operations	-48	6.81	-77	-68	-90	-73	-66	-56	-44	-73
Consolidated Net Income / (Loss)	-48	6.81	-77	-68	-90	-73	-66	-56	-44	-73
Depreciation Expense	2.10	2.33	2.53	2.59	2.60	4.19	2.63	2.67	2.99	4.36
Amortization Expense	-	-	-0.93	-0.91	-4.69	-4.39	-3.70	-2.98	-1.80	-2.43
Non-Cash Adjustments To Reconcile Net Income	-3.61	-61	9.71	12	26	131	24	26	3.92	23
Changes in Operating Assets and Liabilities, net	0.37	-2.68	-12	-2.55	104	-106	-18	-1.76	2.67	-4.43
Net Cash From Investing Activities	-5.06	-168	2.99	46	-314	60	64	78	48	-27
Net Cash From Continuing Investing Activities	-5.06	-168	2.99	46	-314	60	64	78	48	-27
Purchase of Property, Plant & Equipment	-3.99	-5.07	-2.34	-1.07	-1.70	-2.04	-2.34	-0.60	-0.38	-0.04
Purchase of Investments	-	-163	0.00	-	-366	-	-84	-69	-127	-80
Sale and/or Maturity of Investments	-	-	5.33	47	54	62	150	148	183	54
Other Investing Activities, net	-	-	-	-	-	-	-	-	-	-0.02
Net Cash From Financing Activities	0.30	0.60	0.13	370	-7.59	0.05	0.00	0.05	-53	-6.52
Net Cash From Continuing Financing Activities	0.30	0.60	0.13	370	-7.59	0.05	0.00	0.05	-53	-6.52
Issuance of Common Equity	0.30	0.60	0.13	0.08	0.06	0.05	0.00	0.05	0.03	2.04
Other Financing Activities, net	-	-	-	-	-7.65	-	-	-	-	-8.56
Effect of Exchange Rate Changes	-6.49	10	1.03	0.78	-1.39	1.84	-1.73	-0.47	3.99	-6.77
Cash Interest Paid	2.43	2.84	3.06	5.83	4.11	3.88	4.76	4.50	7.63	3.68

This table presents uniQure's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	705	832	557
Total Current Assets	477	652	390
Cash & Equivalents	228	241	159
Short-Term Investments	125	377	209
Accounts Receivable	102	4.19	5.88
Inventories, net	6.92	12	0.00
Prepaid Expenses	12	15	9.28
Other Current Assets	2.81	2.66	7.61
Plant, Property, & Equipment, net	51	47	20
Total Noncurrent Assets	178	133	146
Long-Term Investments	40	2.18	27
Goodwill	26	26	22
Intangible Assets	59	60	71
Noncurrent Deferred & Refundable Income Taxes	15	12	9.86
Other Noncurrent Operating Assets	39	32	15
Total Liabilities & Shareholders' Equity	705	832	557
Total Liabilities	229	624	563
Total Current Liabilities	76	74	40
Short-Term Debt	26	28	0.00
Accounts Payable	11	6.59	7.23
Accrued Expenses	31	31	29
Other Current Liabilities	8.38	8.34	3.60
Total Noncurrent Liabilities	153	550	523
Long-Term Debt	103	102	51
Noncurrent Deferred & Payable Income Tax Liabilities	8.26	7.54	7.04
Other Noncurrent Operating Liabilities	42	441	465
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	476	208	-6.75
Total Preferred & Common Equity	476	208	-6.75
Total Common Equity	476	208	-6.75
Common Stock	1,116	1,152	1,176
Retained Earnings	-582	-890	-1,130
Accumulated Other Comprehensive Income / (Loss)	-58	-54	-53

This table presents uniQure's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	638	631	943	872	770	731	646
Total Current Assets	465	443	757	694	596	592	464
Cash & Equivalents	440	154	514	229	243	288	252
Short-Term Investments	-	161	115	429	313	237	184
Accounts Receivable	3.60	105	103	1.64	11	7.85	5.32
Inventories, net	4.08	7.48	10	16	7.67	0.00	0.00
Prepaid Expenses	14	13	12	15	19	18	19
Other Current Assets	2.89	2.47	3.25	2.53	3.09	3.45	4.29
Plant, Property, & Equipment, net	48	50	49	46	45	26	26
Total Noncurrent Assets	126	138	137	132	129	113	156
Long-Term Investments	-	0.00	0.00	0.00	-	-	28
Goodwill	23	26	26	25	26	23	24
Intangible Assets	54	60	60	58	59	59	77
Noncurrent Deferred & Refundable Income Taxes	15	14	14	12	12	11	11
Other Noncurrent Operating Assets	34	38	38	36	33	20	16
Total Liabilities & Shareholders' Equity	638	631	943	872	770	731	646
Total Liabilities	217	218	589	603	623	634	590
Total Current Liabilities	64	66	68	69	63	80	71
Short-Term Debt	24	27	28	27	28	28	29
Accounts Payable	7.57	8.89	9.37	5.58	5.23	4.41	5.44
Accrued Expenses	26	23	24	28	23	26	32
Other Current Liabilities	6.43	7.67	7.78	7.89	8.00	3.63	4.30
Total Noncurrent Liabilities	153	152	521	534	560	553	519
Long-Term Debt	102	103	101	101	102	103	51
Noncurrent Deferred & Payable Income Tax Liabilities	8.59	6.97	6.80	4.92	7.38	7.32	7.63
Other Noncurrent Operating Liabilities	42	42	413	428	450	443	460
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	421	413	353	269	147	97	56
Total Preferred & Common Equity	421	413	353	269	147	97	56
Total Common Equity	421	413	353	269	147	97	56
Common Stock	1,103	1,124	1,133	1,145	1,159	1,166	1,169
Retained Earnings	-589	-659	-728	-817	-956	-1,012	-1,057
Accumulated Other Comprehensive Income / (Loss)	-93	-52	-52	-59	-56	-56	-57

This table displays calculated financial ratios and metrics derived from uniQure's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	-79.68%	-85.12%	71.17%
EBITDA Growth	-131.27%	-161.06%	31.92%
EBIT Growth	-134.45%	-142.87%	31.54%
NOPAT Growth	-132.58%	-97.59%	34.85%
Net Income Growth	-138.47%	-143.30%	22.34%
EPS Growth	-138.49%	-138.75%	23.96%
Operating Cash Flow Growth	-150.38%	-0.60%	-25.22%
Free Cash Flow Firm Growth	-185.11%	272.64%	-120.59%
Invested Capital Growth	50.88%	-233.26%	-24.07%
Revenue Q/Q Growth	73.34%	-85.84%	-5.14%
EBITDA Q/Q Growth	0.08%	-35.11%	1.02%
EBIT Q/Q Growth	-0.33%	-33.35%	-0.07%
NOPAT Q/Q Growth	14.58%	-45.34%	7.95%
Net Income Q/Q Growth	-1.12%	-35.02%	-0.02%
EPS Q/Q Growth	-3.04%	-34.79%	0.61%
Operating Cash Flow Q/Q Growth	-5.52%	3.40%	-1.84%
Free Cash Flow Firm Q/Q Growth	-22.35%	27.46%	18.41%
Invested Capital Q/Q Growth	98.48%	-7.81%	-7.05%
Profitability Metrics	-	-	-
Gross Margin	98.82%	99.59%	95.33%
EBITDA Margin	-102.01%	-1,789.93%	-711.90%
Operating Margin	-134.44%	-1,785.46%	-679.58%
EBIT Margin	-110.03%	-1,796.14%	-718.32%
Profit (Net Income) Margin	-119.07%	-1,947.09%	-883.35%
Tax Burden Percent	98.85%	100.63%	101.02%
Interest Burden Percent	109.47%	107.73%	121.73%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-56.87%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-49.48%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	33.21%	0.00%	0.00%
Return on Equity (ROE)	-23.66%	-90.24%	-238.46%
Cash Return on Invested Capital (CROIC)	-97.43%	0.00%	0.00%
Operating Return on Assets (OROA)	-15.48%	-37.04%	-28.06%
Return on Assets (ROA)	-16.75%	-40.15%	-34.51%
Return on Common Equity (ROCE)	-23.66%	-90.24%	-238.46%
Return on Equity Simple (ROE_SIMPLE)	-26.64%	-148.54%	3,547.93%
Net Operating Profit after Tax (NOPAT)	-100	-198	-129
NOPAT Margin	-94.11%	-1,249.82%	-475.70%
Net Nonoperating Expense Percent (NNEP)	-7.39%	-29.30%	-26.52%
Return On Investment Capital (ROIC_SIMPLE)	-16.57%	-58.65%	-289.43%
Cost of Revenue to Revenue	1.18%	0.41%	4.67%
SG&A Expenses to Revenue	52.48%	481.48%	211.03%
R&D to Revenue	185.56%	1,356.21%	530.19%
Operating Expenses to Revenue	233.27%	1,885.05%	774.90%
Earnings before Interest and Taxes (EBIT)	-117	-285	-195
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-109	-284	-193
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.23	1.56	0.00
Price to Tangible Book Value (P/TBV)	2.71	2.68	0.00
Price to Revenue (P/Rev)	9.97	20.43	31.74
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.76	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	7.49	0.00	19.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.27	0.63	-7.60
Long-Term Debt to Equity	0.22	0.49	-7.60
Financial Leverage	-0.67	-1.10	-4.15
Leverage Ratio	1.41	2.25	6.91
Compound Leverage Factor	1.55	2.42	8.41
Debt to Total Capital	21.29%	38.49%	115.15%
Short-Term Debt to Total Capital	4.30%	8.36%	0.00%
Long-Term Debt to Total Capital	17.00%	30.14%	115.15%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.71%	61.51%	-15.15%
Debt to EBITDA	-1.19	-0.46	-0.27
Net Debt to EBITDA	2.43	1.73	1.78
Long-Term Debt to EBITDA	-0.95	-0.36	-0.27
Debt to NOPAT	-1.29	-0.66	-0.40
Net Debt to NOPAT	2.64	2.48	2.66
Long-Term Debt to NOPAT	-1.03	-0.51	-0.40
Altman Z-Score	1.91	-1.46	-2.28
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	6.28	8.85	9.74
Quick Ratio	6.00	8.44	9.32
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-172	296	-61
Operating Cash Flow to CapEx	-820.10%	-2,039.82%	-5,425.42%
Free Cash Flow to Firm to Interest Expense	-14.67	7.13	-0.96
Operating Cash Flow to Interest Expense	-12.39	-3.51	-2.87
Operating Cash Flow Less CapEx to Interest Expense	-13.91	-3.68	-2.92
Efficiency Ratios	-	-	-
Asset Turnover	0.14	0.02	0.04
Accounts Receivable Turnover	1.32	0.30	5.38
Inventory Turnover	0.00	0.01	0.00
Fixed Asset Turnover	2.26	0.33	0.81
Accounts Payable Turnover	0.19	0.01	0.18
Days Sales Outstanding (DSO)	276.18	1,227.60	67.79
Days Inventory Outstanding (DIO)	0.00	53,200.15	0.00
Days Payable Outstanding (DPO)	1,962.68	49,331.15	1,989.64
Cash Conversion Cycle (CCC)	-1,686.49	5,096.60	-1,921.84
Capital & Investment Metrics	-	-	-
Invested Capital	212	-282	-350
Invested Capital Turnover	0.60	-0.45	-0.09
Increase / (Decrease) in Invested Capital	71	-494	-68
Enterprise Value (EV)	797	-166	517
Market Capitalization	1,061	324	861
Book Value per Share	$10.17	$4.34	($0.14)
Tangible Book Value per Share	$8.37	$2.53	($2.06)
Total Capital	605	338	45
Total Debt	129	130	51
Total Long-Term Debt	103	102	51
Net Debt	-264	-490	-344
Capital Expenditures (CapEx)	18	7.15	3.37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	74	-12	-17
Debt-free Net Working Capital (DFNWC)	427	606	350
Net Working Capital (NWC)	401	578	350
Net Nonoperating Expense (NNE)	27	110	111
Net Nonoperating Obligations (NNO)	-264	-490	-344
Total Depreciation and Amortization (D&A)	8.54	0.98	1.74
Debt-free, Cash-free Net Working Capital to Revenue	69.49%	-72.61%	-63.74%
Debt-free Net Working Capital to Revenue	400.85%	3,827.49%	1,291.48%
Net Working Capital to Revenue	376.45%	3,649.42%	1,291.48%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.71)	($6.47)	($4.92)
Adjusted Weighted Average Basic Shares Outstanding	46.74M	47.67M	48.65M
Adjusted Diluted Earnings per Share	($2.71)	($6.47)	($4.92)
Adjusted Weighted Average Diluted Shares Outstanding	46.74M	47.67M	48.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.98M	47.84M	54.08M
Normalized Net Operating Profit after Tax (NOPAT)	-100	-198	-129
Normalized NOPAT Margin	-94.11%	-1,249.82%	-475.70%
Pre Tax Income Margin	-120.45%	-1,934.97%	-874.39%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-10.01	-6.85	-3.06
NOPAT to Interest Expense	-8.56	-4.76	-2.02
EBIT Less CapEx to Interest Expense	-11.52	-7.02	-3.11
NOPAT Less CapEx to Interest Expense	-10.07	-4.94	-2.08
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from uniQure's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-27.15%	78.10%	197.15%	387.32%	-2.90%	-93.49%	59.34%	359.37%	62.54%	-21.95%
EBITDA Growth	-31.32%	0.76%	-75.51%	-81.42%	-94.61%	-621.16%	24.69%	28.11%	62.43%	3.22%
EBIT Growth	-30.64%	-3.93%	-70.77%	-76.20%	-80.91%	-746.49%	27.66%	30.45%	60.02%	-0.22%
NOPAT Growth	-32.26%	1,166.39%	-37.15%	-16.08%	-37.57%	-258.15%	26.89%	32.37%	50.87%	25.78%
Net Income Growth	-31.00%	-17.07%	-65.45%	-75.30%	-87.16%	-1,175.45%	15.03%	17.78%	50.45%	-0.08%
EPS Growth	-29.11%	-34.78%	-63.00%	-71.43%	-84.31%	-1,113.33%	16.56%	19.44%	51.60%	1.97%
Operating Cash Flow Growth	-22.00%	-16.12%	-204.55%	-263.55%	179.42%	9.40%	22.64%	42.61%	-194.06%	-6.67%
Free Cash Flow Firm Growth	50.78%	57.45%	-13.05%	281.64%	581.62%	1,122.12%	416.51%	-29.34%	-88.06%	-92.04%
Invested Capital Growth	27.46%	50.88%	73.18%	-251.75%	-345.34%	-233.26%	-222.50%	-116.28%	-24.94%	-24.07%
Revenue Q/Q Growth	191.55%	6,990.75%	-94.82%	-54.52%	-41.91%	375.41%	26.85%	31.13%	-79.44%	128.29%
EBITDA Q/Q Growth	-23.93%	127.56%	-731.65%	15.90%	-32.94%	26.20%	8.72%	19.73%	30.52%	-90.09%
EBIT Q/Q Growth	-22.97%	121.11%	-902.91%	15.47%	-26.26%	24.56%	10.15%	18.73%	27.41%	-89.09%
NOPAT Q/Q Growth	-6.17%	165.60%	-289.97%	12.27%	-25.82%	24.58%	12.18%	18.84%	8.59%	-13.92%
Net Income Q/Q Growth	-22.52%	114.22%	-1,234.52%	11.33%	-30.81%	18.27%	10.37%	14.20%	21.17%	-65.08%
EPS Q/Q Growth	-21.43%	114.71%	-1,186.67%	11.66%	-30.56%	19.15%	10.53%	14.71%	21.55%	-63.74%
Operating Cash Flow Q/Q Growth	-212.48%	-11.61%	-43.20%	27.21%	168.27%	-227.32%	-22.27%	46.00%	-11.88%	-44.39%
Free Cash Flow Firm Q/Q Growth	40.52%	31.74%	-235.84%	233.21%	57.72%	44.86%	4.50%	-70.26%	-73.35%	-3.48%
Invested Capital Q/Q Growth	10.62%	98.48%	7.54%	-164.27%	-78.84%	-7.81%	0.37%	-13.47%	-3.31%	-7.05%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	98.78%	100.00%	100.00%	100.00%	99.03%	98.23%	97.90%	88.46%	88.14%
EBITDA Margin	-2,971.22%	11.55%	-1,407.31%	-2,602.15%	-5,954.94%	-924.35%	-665.16%	-407.21%	-1,376.39%	-1,146.10%
Operating Margin	-4,107.52%	25.79%	-1,392.90%	-2,686.79%	-5,819.26%	-923.13%	-639.10%	-395.56%	-1,758.99%	-877.76%
EBIT Margin	-3,116.36%	9.28%	-1,437.39%	-2,671.35%	-5,806.04%	-921.36%	-652.60%	-404.45%	-1,428.25%	-1,183.01%
Profit (Net Income) Margin	-3,302.76%	6.63%	-1,450.27%	-2,827.17%	-6,366.10%	-1,094.42%	-773.34%	-506.01%	-1,940.45%	-1,403.20%
Tax Burden Percent	99.32%	103.14%	98.46%	100.24%	99.92%	104.32%	101.01%	101.71%	99.93%	101.18%
Interest Burden Percent	106.71%	69.23%	102.47%	105.58%	109.73%	113.86%	117.32%	123.01%	135.96%	117.23%
Effective Tax Rate	0.00%	-3.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1,853.66%	16.07%	-596.67%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-1,852.15%	21.78%	-588.23%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	1,503.35%	-14.62%	367.63%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-350.31%	1.46%	-229.04%	-44.47%	-66.23%	-90.24%	-106.11%	-126.41%	-147.56%	-238.46%
Cash Return on Invested Capital (CROIC)	-147.27%	-97.43%	-117.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-270.99%	1.31%	-227.84%	-363.79%	-860.64%	-19.00%	-17.70%	-13.39%	-53.82%	-46.22%
Return on Assets (ROA)	-287.20%	0.93%	-229.88%	-385.01%	-943.66%	-22.57%	-20.98%	-16.75%	-73.12%	-54.82%
Return on Common Equity (ROCE)	-350.31%	1.46%	-229.04%	-44.47%	-66.23%	-90.24%	-106.11%	-126.41%	-147.56%	-238.46%
Return on Equity Simple (ROE_SIMPLE)	-29.77%	0.00%	-38.12%	-52.86%	-85.00%	0.00%	-202.29%	-293.18%	-429.05%	0.00%
Net Operating Profit after Tax (NOPAT)	-42	27	-52	-46	-57	-43	-38	-31	-28	-32
NOPAT Margin	-2,875.27%	26.60%	-975.03%	-1,880.75%	-4,073.48%	-646.19%	-447.37%	-276.89%	-1,231.29%	-614.43%
Net Nonoperating Expense Percent (NNEP)	-1.51%	-5.71%	-8.45%	-5.15%	-7.63%	-7.95%	-9.06%	-5.58%	-3.55%	-9.88%
Return On Investment Capital (ROIC_SIMPLE)	-	4.52%	-	-	-	-12.80%	-	-	-	-71.97%
Cost of Revenue to Revenue	0.00%	1.22%	0.00%	0.00%	0.00%	0.97%	1.77%	2.10%	11.54%	11.86%
SG&A Expenses to Revenue	933.26%	17.96%	339.23%	883.98%	1,300.78%	276.65%	167.01%	143.83%	589.86%	259.84%
R&D to Revenue	3,317.32%	56.77%	1,141.95%	1,900.74%	4,648.19%	637.15%	479.58%	302.49%	1,337.78%	743.92%
Operating Expenses to Revenue	4,207.52%	72.99%	1,492.90%	2,786.79%	5,919.26%	1,022.16%	737.34%	493.46%	1,847.44%	965.91%
Earnings before Interest and Taxes (EBIT)	-45	9.53	-77	-65	-82	-62	-55	-45	-33	-62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-43	12	-75	-63	-84	-62	-56	-45	-31	-60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.08	2.23	2.29	1.54	1.19	1.56	1.69	2.24	4.30	0.00
Price to Tangible Book Value (P/TBV)	2.55	2.71	2.89	2.04	1.73	2.68	4.02	14.18	0.00	0.00
Price to Revenue (P/Rev)	14.27	9.97	8.60	4.87	2.86	20.43	13.08	7.85	8.40	31.74
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.27	3.76	3.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	9.15	7.49	6.92	0.41	0.00	0.00	0.00	0.00	0.00	19.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.37	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.30	0.27	0.32	0.36	0.48	0.63	0.88	1.34	1.44	-7.60
Long-Term Debt to Equity	0.24	0.22	0.25	0.29	0.38	0.49	0.70	1.06	0.92	-7.60
Financial Leverage	-0.81	-0.67	-0.63	-1.06	-1.22	-1.10	-1.09	-2.03	-2.82	-4.15
Leverage Ratio	1.40	1.41	1.45	1.96	2.19	2.25	2.50	3.72	4.67	6.91
Compound Leverage Factor	1.49	0.98	1.48	2.07	2.40	2.56	2.94	4.57	6.36	8.10
Debt to Total Capital	23.02%	21.29%	24.02%	26.71%	32.28%	38.49%	46.92%	57.35%	59.01%	115.15%
Short-Term Debt to Total Capital	4.30%	4.30%	5.02%	5.74%	6.73%	8.36%	9.98%	12.32%	21.47%	0.00%
Long-Term Debt to Total Capital	18.72%	17.00%	19.01%	20.97%	25.55%	30.14%	36.94%	45.02%	37.54%	115.15%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	76.98%	78.71%	75.98%	73.29%	67.72%	61.51%	53.08%	42.65%	40.99%	-15.15%
Debt to EBITDA	-1.16	-1.19	-0.93	-0.77	-0.61	-0.46	-0.49	-0.53	-0.41	-0.27
Net Debt to EBITDA	2.89	2.43	1.32	2.99	2.53	1.73	1.61	1.59	1.96	1.78
Long-Term Debt to EBITDA	-0.94	-0.95	-0.74	-0.60	-0.48	-0.36	-0.39	-0.41	-0.26	-0.27
Debt to NOPAT	-1.07	-1.29	-1.14	-1.07	-0.94	-0.66	-0.70	-0.77	-0.57	-0.40
Net Debt to NOPAT	2.68	2.64	1.62	4.14	3.90	2.48	2.31	2.33	2.73	2.66
Long-Term Debt to NOPAT	-0.87	-1.03	-0.90	-0.84	-0.74	-0.51	-0.55	-0.61	-0.36	-0.40
Altman Z-Score	1.75	2.50	1.63	0.24	-0.31	-0.58	-0.88	-1.06	-1.44	-1.49
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.26	6.28	6.67	11.07	10.11	8.85	9.39	7.36	6.51	9.74
Quick Ratio	6.94	6.00	6.33	10.70	9.63	8.44	8.92	6.61	6.18	9.32
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-65	-44	-148	197	311	451	469	140	37	36
Operating Cash Flow to CapEx	-1,229.39%	-1,079.35%	-3,343.38%	-5,306.98%	2,288.88%	-2,430.86%	-2,584.26%	-5,415.73%	-9,631.05%	-132,110.00%
Free Cash Flow to Firm to Interest Expense	-21.07	-12.88	-41.62	28.87	20.17	28.72	29.15	8.64	2.24	2.41
Operating Cash Flow to Interest Expense	-15.96	-15.96	-21.98	-8.33	2.52	-3.15	-3.76	-2.02	-2.20	-3.55
Operating Cash Flow Less CapEx to Interest Expense	-17.26	-17.44	-22.64	-8.49	2.41	-3.28	-3.91	-2.06	-2.23	-3.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.09	0.14	0.16	0.14	0.15	0.02	0.03	0.03	0.04	0.04
Accounts Receivable Turnover	16.66	1.32	1.53	2.12	42.65	0.30	0.33	0.50	8.21	5.38
Inventory Turnover	0.00	0.00	0.00	0.19	0.13	0.01	0.03	0.00	0.00	0.00
Fixed Asset Turnover	1.38	2.26	2.32	2.37	2.39	0.33	0.40	0.74	0.80	0.81
Accounts Payable Turnover	0.28	0.19	0.13	0.13	0.19	0.01	0.03	0.07	0.13	0.18
Days Sales Outstanding (DSO)	21.91	276.18	237.94	172.29	8.56	1,227.60	1,109.33	727.24	44.47	67.79
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	1,915.38	2,871.25	53,200.15	12,859.03	0.00	0.00	0.00
Days Payable Outstanding (DPO)	1,313.33	1,962.68	2,736.77	2,823.51	1,913.78	49,331.15	11,982.19	5,601.00	2,821.97	1,989.64
Cash Conversion Cycle (CCC)	-1,291.42	-1,686.49	-2,498.83	-735.84	966.03	5,096.60	1,986.18	-4,873.76	-2,777.50	-1,921.84
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	107	212	228	-146	-262	-282	-279	-317	-327	-350
Invested Capital Turnover	0.64	0.60	0.61	-4.48	-1.44	-0.45	-0.74	-0.12	-0.10	-0.09
Increase / (Decrease) in Invested Capital	23	71	96	-243	-369	-494	-507	-170	-65	-68
Enterprise Value (EV)	562	797	761	46	-211	-166	-177	-176	-143	517
Market Capitalization	877	1,061	946	545	320	324	249	218	240	861
Book Value per Share	$9.01	$10.17	$8.79	$7.43	$5.63	$4.34	$3.03	$2.00	$1.15	($0.14)
Tangible Book Value per Share	$7.36	$8.37	$6.96	$5.62	$3.89	$2.53	$1.28	$0.32	($0.92)	($2.06)
Total Capital	547	605	543	482	397	338	276	228	136	45
Total Debt	126	129	131	129	128	130	130	131	80	51
Total Long-Term Debt	102	103	103	101	101	102	102	103	51	51
Net Debt	-314	-264	-185	-500	-531	-490	-426	-394	-383	-344
Capital Expenditures (CapEx)	3.99	5.07	2.34	1.07	1.70	2.04	2.34	0.60	0.38	0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-16	74	88	88	-7.19	-12	4.43	15	-13	-17
Debt-free Net Working Capital (DFNWC)	424	427	404	716	652	606	560	540	422	350
Net Working Capital (NWC)	401	401	376	689	625	578	533	512	393	350
Net Nonoperating Expense (NNE)	6.19	21	25	23	32	30	28	25	16	41
Net Nonoperating Obligations (NNO)	-314	-264	-185	-500	-531	-490	-426	-414	-383	-344
Total Depreciation and Amortization (D&A)	2.10	2.33	1.60	1.68	-2.10	-0.20	-1.07	-0.31	1.19	1.93
Debt-free, Cash-free Net Working Capital to Revenue	-26.33%	69.49%	80.19%	78.33%	-6.42%	-72.61%	23.33%	54.61%	-45.98%	-63.74%
Debt-free Net Working Capital to Revenue	690.46%	400.85%	366.82%	639.86%	582.42%	3,827.49%	2,947.52%	1,947.38%	1,476.54%	1,291.48%
Net Working Capital to Revenue	652.14%	376.45%	342.05%	615.15%	558.56%	3,649.42%	2,802.35%	1,846.10%	1,374.28%	1,291.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.02)	$0.15	($1.63)	($1.44)	($1.88)	($1.52)	($1.36)	($1.16)	($0.91)	($1.49)
Adjusted Weighted Average Basic Shares Outstanding	46.77M	46.74M	47.44M	47.65M	47.77M	47.67M	48.38M	48.62M	48.72M	48.65M
Adjusted Diluted Earnings per Share	($1.02)	$0.15	($1.63)	($1.44)	($1.88)	($1.52)	($1.36)	($1.16)	($0.91)	($1.49)
Adjusted Weighted Average Diluted Shares Outstanding	46.77M	46.74M	47.44M	47.65M	47.77M	47.67M	48.38M	48.62M	48.72M	48.65M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.82M	46.98M	47.58M	47.70M	47.81M	47.84M	48.55M	48.70M	48.74M	54.08M
Normalized Net Operating Profit after Tax (NOPAT)	-42	19	-52	-46	-57	-43	-38	-31	-28	-32
Normalized NOPAT Margin	-2,875.27%	18.05%	-975.03%	-1,880.75%	-4,073.48%	-646.19%	-447.37%	-276.89%	-1,231.29%	-614.43%
Pre Tax Income Margin	-3,325.47%	6.42%	-1,472.94%	-2,820.44%	-6,371.00%	-1,049.07%	-765.61%	-497.49%	-1,941.80%	-1,386.80%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-14.71	2.78	-21.49	-9.46	-5.29	-3.92	-3.44	-2.79	-1.97	-4.15
NOPAT to Interest Expense	-13.58	7.98	-14.58	-6.66	-3.71	-2.75	-2.36	-1.91	-1.70	-2.16
EBIT Less CapEx to Interest Expense	-16.01	1.30	-22.15	-9.62	-5.40	-4.05	-3.59	-2.82	-1.99	-4.15
NOPAT Less CapEx to Interest Expense	-14.87	6.50	-15.23	-6.82	-3.82	-2.88	-2.50	-1.94	-1.72	-2.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About uniQure's Financials

When does uniQure's financial year end?

According to the most recent income statement we have on file, uniQure's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has uniQure's net income changed over the last 2 years?

uniQure's net income appears to be on an upward trend, with a most recent value of -$239.56 million in 2024, rising from -$126.79 million in 2022. The previous period was -$308.48 million in 2023. See where experts think uniQure is headed by visiting uniQure's forecast page.

What is uniQure's operating income?

uniQure's total operating income in 2024 was -$184.29 million, based on the following breakdown:

Total Gross Profit: $25.85 million
Total Operating Expenses: $210.15 million

How has uniQure revenue changed over the last 2 years?

Over the last 2 years, uniQure's total revenue changed from $106.48 million in 2022 to $27.12 million in 2024, a change of -74.5%.

How much debt does uniQure have?

uniQure's total liabilities were at $563.29 million at the end of 2024, a 9.7% decrease from 2023, and a 146.0% increase since 2022.

How much cash does uniQure have?

In the past 2 years, uniQure's cash and equivalents has ranged from $158.93 million in 2024 to $241.36 million in 2023, and is currently $158.93 million as of their latest financial filing in 2024.

How has uniQure's book value per share changed over the last 2 years?

Over the last 2 years, uniQure's book value per share changed from 10.17 in 2022 to -0.14 in 2024, a change of -101.4%.

Related Companies

This page (NASDAQ:QURE) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

uniQure (QURE) Financials

Frequently Asked Questions About uniQure's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

uniQure (QURE) Financials

Annual Income Statements for uniQure

Quarterly Income Statements for uniQure

Annual Cash Flow Statements for uniQure

Quarterly Cash Flow Statements for uniQure

Annual Balance Sheets for uniQure

Quarterly Balance Sheets for uniQure

Annual Metrics and Ratios for uniQure

Quarterly Metrics and Ratios for uniQure

Frequently Asked Questions About uniQure's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools